Efficient HIV-1 replication can occur in the absence of the viral matrix protein

被引:207
作者
Reil, H
Bukovsky, AA
Gelderblom, HR
Göttlinger, HG [1 ]
机构
[1] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[3] Robert Koch Inst, D-1000 Berlin, Germany
关键词
cytoplasmic domain; envelope; HIV-1; matrix protein; virus replication;
D O I
10.1093/emboj/17.9.2699
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix (MA), a major structural protein of retroviruses, is thought to play a critical role in several steps of the HIV-1 replication cycle, including the plasma membrane targeting of Gag, the incorporation of envelope (Env) glycoproteins into nascent particles, and the nuclear import of the viral genome in nondividing cells. We now show that the entire MA protein is dispensable for the incorporation of HIV-1 Env glycoproteins with a shortened cytoplasmic domain. Furthermore, efficient HIV-1 replication in the absence of up to 90% of MA was observed in a cell line in which the cytoplasmic domain of Env is not required. Additional compensatory changes in Gag permitted efficient virus replication even if all of MA was replaced by a heterologous membrane targeting signal. Viruses which lacked the globular domain of MA but retained its N-terminal myristyl anchor exhibited an increased ability to form both extracellular and intracellular virus particles, consistent with a myristyl switch model of Gag membrane targeting. Pseudotyped HIV-1 particles that lacked the structurally conserved globular head of MA efficiently infected macrophages, indicating that MA is dispensable for nuclear import in terminally differentiated cells.
引用
收藏
页码:2699 / 2708
页数:10
相关论文
共 53 条
[2]   MYRISTOYLATION-DEPENDENT REPLICATION AND ASSEMBLY OF HUMAN IMMUNODEFICIENCY VIRUS-1 [J].
BRYANT, M ;
RATNER, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (02) :523-527
[3]   Phosphorylation-dependent human immunodeficiency virus type 1 infection and nuclear targeting of viral DNA [J].
Bukrinskaya, AG ;
Ghorpade, A ;
Heinzinger, NK ;
Smithgall, TE ;
Lewis, RE ;
Stevenson, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (01) :367-371
[4]   A NUCLEAR-LOCALIZATION SIGNAL WITHIN HIV-1 MATRIX PROTEIN THAT GOVERNS INFECTION OF NONDIVIDING CELLS [J].
BUKRINSKY, MI ;
HAGGERTY, S ;
DEMPSEY, MP ;
SHAROVA, N ;
ADZHUBEI, A ;
SPITZ, L ;
LEWIS, P ;
GOLDFARB, D ;
EMERMAN, M ;
STEVENSON, M .
NATURE, 1993, 365 (6447) :666-669
[5]   ACTIVE NUCLEAR IMPORT OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PREINTEGRATION COMPLEXES [J].
BUKRINSKY, MI ;
SHAROVA, N ;
DEMPSEY, MP ;
STANWICK, TL ;
BUKRINSKAYA, AG ;
HAGGERTY, S ;
STEVENSON, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) :6580-6584
[6]   Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17 [J].
Cannon, PM ;
Matthews, S ;
Clark, N ;
Byles, ED ;
Iourin, O ;
Hockley, DJ ;
Kingsman, SM ;
Kingsman, AJ .
JOURNAL OF VIROLOGY, 1997, 71 (05) :3474-3483
[7]   Three-dimensional structure of the HTLV-II matrix protein and comparative analysis of matrix proteins from the different classes of pathogenic human retroviruses [J].
Christensen, AM ;
Massiah, MA ;
Turner, BG ;
Sundquist, WI ;
Summers, MF .
JOURNAL OF MOLECULAR BIOLOGY, 1996, 264 (05) :1117-1131
[8]   The three-dimensional solution structure of the matrix protein from the type D retrovirus, the Mason-Pfizer monkey virus, and implications for the morphology of retroviral assembly [J].
Conte, MR ;
Klikova, M ;
Hunter, E ;
Ruml, T ;
Matthews, S .
EMBO JOURNAL, 1997, 16 (19) :5819-5826
[9]   Direct interaction between the envelope and matrix proteins of HIV-1 [J].
Cosson, P .
EMBO JOURNAL, 1996, 15 (21) :5783-5788
[10]   ROLE OF THE MATRIX PROTEIN IN THE VIRION ASSOCIATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN [J].
DORFMAN, T ;
MAMMANO, F ;
HASELTINE, WA ;
GOTTLINGER, HG .
JOURNAL OF VIROLOGY, 1994, 68 (03) :1689-1696